NexImmune (NEXI) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free NEXI Stock Alerts $3.29 +0.08 (+2.49%) (As of 05/21/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 10:42 PM | msn.comNEXI Stock Earnings: NexImmune Reported Results for Q1 2024April 17, 2024 | investorplace.comNEXI Stock Earnings: NexImmune Reported Results for Q4 2023April 16, 2024 | theglobeandmail.comAcute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsightApril 15, 2024 | msn.comPortage mulls company closure, pauses enrolment for lead clinical programmeApril 2, 2024 | msn.comXilio fires 21% of its workforce and reprioritises pipelineFebruary 7, 2024 | msn.comNexImmune Announces New Offerings in Recent Press ReleaseFebruary 6, 2024 | markets.businessinsider.comNexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesFebruary 6, 2024 | msn.comNexImmune Secures Funding Through Equity and Warrant SalesFebruary 3, 2024 | msn.comNexImmune Ends Stock Sale Agreement, Raises $5.1 MillionFebruary 2, 2024 | msn.comNexImmune slips after securities offeringFebruary 2, 2024 | finance.yahoo.comNexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesFebruary 2, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. January 31, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause." Trading set to resume at 10:01 AM. January 31, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:01 PM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 11:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 10:01 AM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 12:01 PM with a stated reason of "LULD pause." Trading set to resume at 12:01 PM. January 13, 2024 | nasdaq.comNexImmune, Inc. Common Stock (NEXI)January 10, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 9, 2024 | investorplace.comNexImmune (NEXI) Stock Rockets 80% Ahead of Potential LiquidationJanuary 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 10:01 AM with a stated reason of "LULD pause."January 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 5, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."December 26, 2023 | bizjournals.comNexImmune's future in limbo as Gaithersburg biotech extends liquidation voteDecember 10, 2023 | ca.finance.yahoo.comNexImmune, Inc. (NEXI) Stock Price, News, Quote & History - Yahoo FinanceDecember 4, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:12 AM with a stated reason of "LULD pause."December 1, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:12 PM with a stated reason of "LULD pause."December 1, 2023 | investorplace.comNEXI Stock Halted: What’s Going on With NexImmune Shares Today?December 1, 2023 | investorplace.comWhy Is NexImmune (NEXI) Stock Up 353% Today?December 1, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 08:12 AM with a stated reason of "News pending."November 23, 2023 | morningstar.comNexImmune Inc Ordinary Shares NEXINovember 8, 2023 | bizjournals.comGaithersburg’s NexImmune prepares to shut down, lay off ‘substantially all’ employeesNovember 6, 2023 | msn.comWhat's Going On With Neximmune (NEXI) Stock Monday?November 3, 2023 | msn.comWhy Neximmune (NEXI) Stock Is Getting HammeredNovember 3, 2023 | marketwatch.comNexImmune Shares Slide Premarket as Biotech Says It Will LiquidateNovember 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 10:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."October 24, 2023 | finance.yahoo.comNexImmune, Yale, and JDRF Extend Research Partnership for Type 1 DiabetesOctober 19, 2023 | finance.yahoo.comNexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual MeetingOctober 18, 2023 | finanznachrichten.deNexImmune, Inc.: NexImmune Announces 1-for-25 Reverse Stock SplitOctober 18, 2023 | finance.yahoo.comNexImmune Announces 1-for-25 Reverse Stock SplitOctober 4, 2023 | msn.comEY report finds cracks in pharma supply chain operationsSeptember 1, 2023 | msn.comNexImmune to lay off over half of its employeesAugust 31, 2023 | seekingalpha.comNexImmune announces 53% reduction in workforceAugust 31, 2023 | marketwatch.comNexImmune to Cut Workforce by More Than Half to Reduce Costs, Extend Cash Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address This Could be Your “Big Money” AI Moment (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. NEXI Media Mentions By Week NEXI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEXI News Sentiment▼0.690.44▲Average Medical News Sentiment NEXI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEXI Articles This Week▼21▲NEXI Articles Average Week Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: China Pharma News Today Kazia Therapeutics News Today Cingulate News Today Bright Minds Biosciences News Today Kintara Therapeutics News Today TFF Pharmaceuticals News Today TransCode Therapeutics News Today Artelo Biosciences News Today Synaptogenix News Today GT Biopharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEXI) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.